Skip to main content

Table 4 Weighted prevalence of T. gondii infection adjusted by risk factor (with or without) and diagnostic method

From: A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population

Population studied-diagnostic method

Number of groups

Number of cases

Positive cases

A/Nx100 prevalence (%)

Meta-analysis prevalence (%)

Lower limit (%)

Upper limit (%)

with Risk - STA

4

480

103

21.45

13.39

10.35

16.44

without Risk -STA

6

1268

340

22.81

22.48

20.32

24.65

without Risk-LF

1

367

73

19.89

19.89

15.8

23.97

without-risk CF

1

58

14

24.14

22.16

13.64

35.15

without Risk-SF

32

22245

6674

30

30

29.4

30.59

with Risk-SF

1

2320

815

35.13

35.12

33.18

37.18

without Risk-IFI-G

36

29997

9597

31.99

29.3

28.81

29.79

with Risk-IFI-G

5

1295

224

16.77

5.58

4.44

6.77

without Risk-IHA

6

3837

151

3.94

2.63

1.24

4.02

with Risk-ELISA-G

18

1963

523

26.64

17.66

16.17

19.15

without Risk-ELISA-G

22

6293

748

11.89

8.92

8.24

9.6

Total

132

70,123

19,262

  
  1. Complement Fixation (CF), Skin test antigen toxoplasmin (STA), Latex Floculation (LF), Sabin and Feldman (SF), Indirect Hemaglutination (IHA), Indirect Fluorescence (IFI), Enzyme-linked immunosorbet assay (ELISA). All prevalences calculated by meta-analysis were statistically significant (p < 0.001).